Tristetraprolin Prevents Gastric Metaplasia in Mice by Suppressing Pathogenic Inflammation
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Cellular and Molecular Gastroenterology and Hepatology
- Vol. 12 (5) , 1831-1845
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- NIGMS (P20GM103434, P30GM103488, P30GM103503, U54GM104942)
- National Institute of Environmental Health Sciences (1ZIAES090057, 1ZIAES090080)
- NCRR (P20RR016440)
- West Virginia University (P20GM121322)
- National Institutes of Health
This publication has 62 references indexed in Scilit:
- Transgenic Expression of Interferon-γ in Mouse Stomach Leads to Inflammation, Metaplasia, and DysplasiaThe American Journal of Pathology, 2012
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Tamoxifen Induces Rapid, Reversible Atrophy, and Metaplasia in Mouse StomachGastroenterology, 2012
- Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veteransCancer, 2010
- Gene Expression Profiling of Metaplastic Lineages Identifies CDH17 as a Prognostic Marker in Early Stage Gastric CancerGastroenterology, 2010
- Tristetraprolin Impairs NF-κB/p65 Nuclear TranslocationJournal of Biological Chemistry, 2009
- RNA-destabilizing Factor Tristetraprolin Negatively Regulates NF-κB SignalingJournal of Biological Chemistry, 2009
- Overexpression of Interleukin-1β Induces Gastric Inflammation and Cancer and Mobilizes Myeloid-Derived Suppressor Cells in MiceCancer Cell, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- Helicobacter pylori and gastrointestinal tract adenocarcinomasNature Reviews Cancer, 2002